Congratulations to Dr. Hermann Einsele and Dr. Noopur Raje, who will be honored today for their extraordinary contributions to myeloma at the 2026 IMWG Summit in Stockholm, Sweden. Learn more: https://www.myeloma.org/node/12929 #IMFIMWG
Congrats on getting this up and running. Will be an incredible resource for patients and clinicians.
Beautiful work and congratulations on starting your own lab. Look forward to seeing what you’ll do and hope we can work together again in the future.
Registration is open for #IMS26! Secure your spot now and join your colleagues in Glasgow ➡️ http://bit.ly/4cdFJkH
We are actively recruiting a postdoctoral fellow to join our lab @jacksonlab! 😎 Details and link to apply: thejacksonlaboratory.wd503.myworkdayjobs.com/External_JAX...
At #AACR26: Results from CAR-PRISM Trial. Dr. Omar Nadeem says in a small trial for pts with high-risk smoldering myeloma, "This is the 1st time we've seen universal minimal residual disease negativity with a one-time treatment administration." @danafarber.bsky.social
➡️ bit.ly/4tmxcmW
After a fantastic MGR today, we are thrilled to welcome Dr. Ross Levine back for our #hematology seminar tomorrow - very thankful to Ross for such & engaging & fun visit! #MPNsm @stanforddeptmed.bsky.social @rosslevinemd.bsky.social @mskcancercenter.bsky.social
Excited that our paper describing a phase 1 trial of ducabtagene autloeucel, a rapidly manufactured anti-BCMA CAR-T in r/r multiple myeloma, was published. #ScienceTranslationalMedicine
Huge thanks to all my co-authors, the teams at @danafarber.bsky.social and Novartis, and to our patients.
Postdoctoral Associate Trowbridge Lab Bar Harbor, ME A Postdoctoral Associate position is available in Dr. Jennifer Trowbridge’s laboratory at The Jackson Laboratory in Bar Harbor, Maine. The Trowbrid...thejacksonlaboratory.wd503.myworkdayjobs.com
Durcabtagene autoleucel, a rapidly manufactured BCMA-directed CAR T cell therapy, was safe and efficacious in relapsed/refractory multiple myeloma.
A rapid manufacturing pipeline for BCMA-targeting CAR T cells drastically shortens “vein-to-vein” times, and produces cells that demonstrate encouraging safety results in a phase one trial of patients with relapsed #MultipleMyeloma. #ScienceTranslationalMedicine https://scim.ag/4fd3JaW
Let’s do some discourse.
Who has the best breakfasts? My vote is Mexico: huevos rancheros/divorciados, chilaquiles, molletes, tetelas, papas con chorizo, churros, migas… plus café de olla
I dunno, I think they figured it out?
After largely running our clinical whole genome sequencing test for #myeloma, JAYseq, in stealth mode for the last 6 months I am extremely proud to see the culmination of years of research effort by my team at TGen and collaborators around the world come to fruition in a clinical test.
